Page 67 - GPD-3-2

Gene & Protein in Disease TOPK: Target for lung cancer treatment

doi: 10.1093/annonc/mdx703 Drug Discov. 2018;17(5):317-332.
63. Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schiöth HB. doi: 10.1038/nrd.2018.14
Trends in kinase drug discovery: Targets, indications and 65. Yang P, Meng M, Zhou Q. Oncogenic cancer/testis antigens
inhibitor design. Nat Rev Drug Discov. 2021;20(11):839-861.
are a hallmarker of cancer and a sensible target for cancer
doi: 10.1038/s41573-021-00252-y immunotherapy. Biochim Biophys Acta Rev Cancer.
2021;1876(1):188558.
64. Oprea TI, Bologa CG, Brunak S, et al. Unexplored
therapeutic opportunities in the human genome. Nat Rev doi: 10.1016/j.bbcan.2021.188558

Volume 3 Issue 2 (2024) 11 doi: 10.36922/gpd.3062